102 related articles for article (PubMed ID: 29608403)
21. A new class of antimetabolites: pyridine thioglycosides as potential anticancer agents.
Elgemeie GH; Mahdy EM; Elgawish MA; Ahmed MM; Shousha WG; Eldin ME
Z Naturforsch C J Biosci; 2010; 65(9-10):577-87. PubMed ID: 21138059
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihydrofolate reductase and thymidylate synthase and as potential antitumor agents.
Gangjee A; Lin X; Kisliuk RL; McGuire JJ
J Med Chem; 2005 Nov; 48(23):7215-22. PubMed ID: 16279780
[TBL] [Abstract][Full Text] [Related]
23. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
Senkovich O; Schormann N; Chattopadhyay D
Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
[TBL] [Abstract][Full Text] [Related]
24. Substrate channeling and domain-domain interactions in bifunctional thymidylate synthase-dihydrofolate reductase.
Liang PH; Anderson KS
Biochemistry; 1998 Sep; 37(35):12195-205. PubMed ID: 9724533
[TBL] [Abstract][Full Text] [Related]
25. Heterologous expression and characterization of the bifunctional dihydrofolate reductase-thymidylate synthase enzyme of Toxoplasma gondii.
Trujillo M; Donald RG; Roos DS; Greene PJ; Santi DV
Biochemistry; 1996 May; 35(20):6366-74. PubMed ID: 8639582
[TBL] [Abstract][Full Text] [Related]
26. Quartz crystal microbalance with dissipation and microscale thermophoresis as tools for investigation of protein complex formation between thymidylate synthesis cycle enzymes.
Antosiewicz A; Senkara E; Cieśla J
Biosens Bioelectron; 2015 Feb; 64():36-42. PubMed ID: 25189098
[TBL] [Abstract][Full Text] [Related]
27. 6-Amino-2,4,5-trimethylpyridin-3-ol and 2-amino-4,6-dimethylpyrimidin-5-ol derivatives as selective fibroblast growth factor receptor 4 inhibitors: design, synthesis, molecular docking, and anti-hepatocellular carcinoma efficacy evaluation.
Chaudhary CL; Lim D; Chaudhary P; Guragain D; Awasthi BP; Park HD; Kim JA; Jeong BS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):844-856. PubMed ID: 35296193
[TBL] [Abstract][Full Text] [Related]
28. Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2-carboxylate derivatives: in vitro evaluation, cell cycle analysis and QSAR studies.
Abreu RM; Ferreira IC; Calhelha RC; Lima RT; Vasconcelos MH; Adega F; Chaves R; Queiroz MJ
Eur J Med Chem; 2011 Dec; 46(12):5800-6. PubMed ID: 22014996
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, Biological Evaluation and Molecular Docking Studies of 6-Aryl-2-Styrylquinazolin-4(3H)-Ones.
Agbo EN; Makhafola TJ; Choong YS; Mphahlele MJ; Ramasami P
Molecules; 2015 Dec; 21(1):E28. PubMed ID: 26712730
[TBL] [Abstract][Full Text] [Related]
30. Subunit complementation of thymidylate synthase in Plasmodium falciparum bifunctional dihydrofolate reductase-thymidylate synthase.
Chanama M; Chitnumsub P; Yuthavong Y
Mol Biochem Parasitol; 2005 Jan; 139(1):83-90. PubMed ID: 15610822
[TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of a new class of indeno[1,2-b]pyridine thioglycosides.
Elgemeie GH; Fathy NM; Farag AB; Yahab AMB
Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1134-1149. PubMed ID: 32600173
[TBL] [Abstract][Full Text] [Related]
32. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.
Chen CY; Chang YL; Shih JY; Lin JW; Chen KY; Yang CH; Yu CJ; Yang PC
Lung Cancer; 2011 Oct; 74(1):132-8. PubMed ID: 21367480
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
[TBL] [Abstract][Full Text] [Related]
35. 2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes.
Piras S; Carta A; Briguglio I; Corona P; Paglietti G; Luciani R; Costi MP; Ferrari S
Eur J Med Chem; 2014 Mar; 75():169-83. PubMed ID: 24531230
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis.
Vargo MA; Martucci WE; Anderson KS
Biochem J; 2009 Feb; 417(3):757-64. PubMed ID: 18851711
[TBL] [Abstract][Full Text] [Related]
37. Design, Synthesis, Molecular Docking Study and Anti-Hepatocellular Carcinoma Evaluation of New Bis-Triazolothiadiazines.
Gomha SM; Muhammad ZA; Ezz El-Arab E; Elmetwally AM; El-Sayed AA; Matar IK
Mini Rev Med Chem; 2020; 20(9):788-800. PubMed ID: 31613728
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.
Iqbal S; Sebhaoui J; Ashraf S; Ozcan M; Kim W; Belmen B; Yeşilyurt G; Hanashalshahaby E; Zhang C; Uhlen M; Boren J; Turkez H; Mardinoglu A
Bioorg Chem; 2024 Jun; 147():107425. PubMed ID: 38714117
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma.
Elshaier YAMM; Shaaban MA; Abd El Hamid MK; Abdelrahman MH; Abou-Salim MA; Elgazwi SM; Halaweish F
Bioorg Med Chem; 2017 Jun; 25(12):2956-2970. PubMed ID: 28487127
[TBL] [Abstract][Full Text] [Related]
40. Structural variations of piritrexim, a lipophilic inhibitor of human dihydrofolate reductase: synthesis, antitumor activity and molecular modeling investigations.
Zink M; Lanig H; Troschütz R
Eur J Med Chem; 2004 Dec; 39(12):1079-88. PubMed ID: 15571870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
